Drug profile · INN
avalglucosidase alfa
NEXVIADYME
avalglucosidase alfa (NEXVIADYME) is a glycogen hydrolytic enzyme.
EMA: approved PMDA: approved Alimentary tract and metabolism (A16) A16
Patents linked 0
Pipeline programs 4
News articles 1
Drug details — avalglucosidase alfa
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
avalglucosidase alfa (NEXVIADYME) is a glycogen hydrolytic enzyme.
Key facts
INN avalglucosidase alfa
Brand NEXVIADYME
Mechanism Glycogen hydrolytic enzyme
Target Glycogen
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16
Mechanism of action
Glycogen hydrolytic enzyme
Primary target: Glycogen
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is avalglucosidase alfa?
avalglucosidase alfa (NEXVIADYME) is a glycogen hydrolytic enzyme.
What is the brand name for avalglucosidase alfa?
NEXVIADYME is a marketed brand name for avalglucosidase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.